Nasdaq, OTC · ADR · Pharmaceutical Preparations
43 entities across 32 jurisdictions, 7 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| BeiGene 101 | Cayman Islands | offshore centre |
| BeOne Medicines Argentina S.R.L | Argentina | |
| BeOne Medicines AUS PTY LTD | Australia | |
| BeOne Medicines Austria GmbH | Austria | |
| BeOne Medicines Belgium SRL | Belgium | |
| BeOne Medicines Brasil Ltda. | Brazil | |
| BeOne Medicines (Canada) ULC | Canada | |
| BeOne Medicines Chile Limitada | Chile | |
| BeOne Medicines Colombia S.A.S. | Colombia | |
| BeOne Medicines ESP, S.L.U. (Spain) | Spain | |
| BeOne Medicines France Sarl | France | |
| BeOne Medicines Germany GmbH | Germany | |
| BeOne Medicines (Hong Kong) Co., Limited | Hong Kong | |
| BeOne Medicines International GmbH | Switzerland | |
| BeOne Medicines Italy S.r.l. | Italy | |
| BeOne Medicines Japan | Japan | |
| BeOne Medicines Korea Y.H. | South Korea | |
| BeOne Medicines Malaysia Sdn Bhd. | Malaysia | |
| BeOne Medicines Mexico S. de R.L. de C.V. | Mexico | |
| BeOne Medicines Netherlands B.V. | Netherlands | |
| BeOne Medicines NZ Unlimited | New Zealand | |
| BeOne Medicines Peru (Sociedad Comercial de Responsabilidad Limitada - S.R.L) | Peru | |
| BeOne Medicines Pharmaceuticals GmbH | Switzerland | |
| BeOne Medicines Israel Ltd. | Israel | |
| BeOne Medicines Poland sp. z o.o. | Poland | |
| BeOne Medicines Portugal, Unipessoal Lda | Portugal | |
| BeiGene Shanghai | Cayman Islands | offshore centre |
| BeiGene Shanghai 101 | Cayman Islands | offshore centre |
| BeOne Medicines Shanghai Asset Limited | Hong Kong | |
| BeOne Medicines Singapore Pte. Ltd | Singapore | |
| BeOne Medicines South Africa (PTY) Ltd. | South Africa | |
| BeOne Medicines Sweden AB | Sweden | |
| BeOne Medicines (Taiwan) Limited | Taiwan | |
| BeiGene (Thailand) Ltd. | Thailand | |
| BeiGene Turkey Medical Products Trade Limited Company | Turkey | |
| BeOne Medicines UK, Ltd. | United Kingdom | |
| BeOne Medicines United Kingdom, Ltd. | United Kingdom | |
| BeOne Medicines Global Business Services Sp. Z o.o. | Poland | |
| BG NC 1, Ltd. | Cayman Islands | offshore centre |
| BG NC 2, Ltd. | Cayman Islands | offshore centre |
| Newco 101 | Cayman Islands | offshore centre |
| BeOne Medicines Treasury Ltd. | Cayman Islands | offshore centre |
| BeOne Medicines I GmbH | Switzerland |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $308.9M | −$1.6B | −$1.4B | — | 1,085,131,783 |
| FY2021 | $1.2B | −$1.4B | −$1.6B | 86.0% | 1,206,210,049 |
| FY2022 | $1.4B | −$2.0B | −$1.8B | 79.8% | 1,340,729,572 |
| FY2023 | $2.5B | −$881.7M | −$1.7B | 84.5% | 1,357,034,547 |
| FY2024 | $3.8B | −$644.8M | −$633.3M | 84.4% | 1,368,746,793 |
| FY2025 | $5.3B | $286.9M | $941.7M | 87.5% | 1,474,829,908 |
13 institutions tracked — 11 added, 2 reduced.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| FMR LLC | Active fund | 2,478,527 | −1,215,083 | $706.3M |
| Capital World Investors | Active fund | 2,249,582 | +626,895 | $641.1M |
| CITADEL ADVISORS LLC | Hedge fund | 1,445,817 | +393,319 | $412.0M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 758,752 | +218,983 | $216.2M |
| JPMORGAN CHASE & CO | Active fund | 188,405 | +110,867 | $54.6M |
| BlackRock, Inc. | Index | 694,618 | +37,117 | $197.9M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 101,980 | +36,524 | $29.1M |
| BANK OF AMERICA CORP /DE/ | Active fund | 439,336 | +34,063 | $125.2M |
| MORGAN STANLEY | Active fund | 497,437 | +32,965 | $141.8M |
| STATE STREET CORP | Index | 714 | −6,351 | $203,469 |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 22,738 | +1,910 | $6.5M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 27,617 | +512 | $7.9M |
| BAILLIE GIFFORD & CO | Value | 231 | +226 | $65,828 |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
BeOne Medicines Ltd. files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
